Pharmaceuticals
Legal expertise for pharmaceutical companies, healthcare, and life sciences
Advancing Healthcare Through Legal Excellence
The pharmaceutical and healthcare industries are highly regulated and constantly evolving, driven by scientific advancements, public health needs, and complex ethical considerations. At Winslow Law Co, our Pharma practice provides expert legal advice and support to pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers. We are committed to helping our clients navigate the intricate regulatory landscape and bring innovative products and services to market.
Our team has extensive experience in all aspects of pharmaceutical and healthcare law, including regulatory compliance, clinical trials, intellectual property, marketing and distribution, and product liability. We combine our deep industry knowledge with legal expertise to provide practical, commercially-oriented solutions that help our clients achieve their strategic objectives and contribute to public health.
Our Key Services
A comprehensive suite of legal services for the pharmaceutical and healthcare industries.
Regulatory Compliance
Advising on all aspects of pharmaceutical and medical device regulation, including marketing authorization, manufacturing, and distribution.
Clinical Trials
Assisting with the legal aspects of clinical trials, including ethical approvals, patient informed consent, and regulatory authorizations.
Intellectual Property
Advising on intellectual property protection for pharmaceutical products, medical devices, and biotechnology inventions.
Our Pharma Team
Meet the experts who will help you advance healthcare.
Esquire Steve Winslow
Senior Partner & Founding Attorney
Esquire Steve Winslow is the founding partner of Winslow Law Co, bringing over two decades of legal expertise in corporate law and international business matters. His leadership has been instrumental in establishing the firm's reputation for excellence and client advocacy.
Justin Hamming
Partner
Justin Hamming specializes in intellectual property and technology law, representing clients in complex patent disputes and technology-related legal matters. His expertise spans both domestic and international IP protection.
James O'Connor
Associate Attorney
James O'Connor specializes in banking and finance law, providing counsel on regulatory compliance, financial services regulations, and complex banking transactions.
Our Track Record
A selection of our successful pharmaceutical and healthcare matters.
Obtaining marketing authorization for a new innovative drug in the UK
Assisted a global pharmaceutical company in obtaining marketing authorization for its new drug, navigating complex regulatory procedures and clinical trial requirements.
Defense of a pharmaceutical company in a product liability claim
Successfully defended a major pharmaceutical company against a product liability claim related to one of its drugs, minimizing financial exposure and reputational damage.
Advising on intellectual property protection for a new biotech invention
Provided comprehensive advice to a biotech startup on intellectual property protection for its new invention, including patent strategy and licensing agreements.
Frequently Asked Questions
Your questions about Pharma law in the UK, answered.
Pharmaceutical products in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012. These cover aspects such as marketing authorization, manufacturing, distribution, and advertising.
Clinical trials in the UK must comply with the principles of Good Clinical Practice (GCP) and relevant national regulations. This includes obtaining ethical approval, patient informed consent, and regulatory authorization from the Medicines and Healthcare products Regulatory Agency (MHRA).
Intellectual property protection in the pharmaceutical industry is crucial for protecting innovative drugs and medical devices. Key considerations include patent protection for active pharmaceutical ingredients and formulations, trademark protection for brand names, and data exclusivity for clinical trial data.